1. Home
  2. DYAI vs CIF Comparison

DYAI vs CIF Comparison

Compare DYAI & CIF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DYAI
  • CIF
  • Stock Information
  • Founded
  • DYAI 1979
  • CIF 1988
  • Country
  • DYAI United States
  • CIF United States
  • Employees
  • DYAI N/A
  • CIF N/A
  • Industry
  • DYAI Biotechnology: Biological Products (No Diagnostic Substances)
  • CIF Trusts Except Educational Religious and Charitable
  • Sector
  • DYAI Health Care
  • CIF Finance
  • Exchange
  • DYAI Nasdaq
  • CIF Nasdaq
  • Market Cap
  • DYAI 30.2M
  • CIF 31.1M
  • IPO Year
  • DYAI 2004
  • CIF N/A
  • Fundamental
  • Price
  • DYAI $0.92
  • CIF $1.71
  • Analyst Decision
  • DYAI Strong Buy
  • CIF
  • Analyst Count
  • DYAI 1
  • CIF 0
  • Target Price
  • DYAI $3.00
  • CIF N/A
  • AVG Volume (30 Days)
  • DYAI 100.8K
  • CIF 43.9K
  • Earning Date
  • DYAI 11-12-2025
  • CIF 01-01-0001
  • Dividend Yield
  • DYAI N/A
  • CIF 10.11%
  • EPS Growth
  • DYAI N/A
  • CIF N/A
  • EPS
  • DYAI N/A
  • CIF N/A
  • Revenue
  • DYAI $3,342,195.00
  • CIF N/A
  • Revenue This Year
  • DYAI $18.18
  • CIF N/A
  • Revenue Next Year
  • DYAI $87.65
  • CIF N/A
  • P/E Ratio
  • DYAI N/A
  • CIF N/A
  • Revenue Growth
  • DYAI N/A
  • CIF N/A
  • 52 Week Low
  • DYAI $0.71
  • CIF $1.47
  • 52 Week High
  • DYAI $2.20
  • CIF $1.77
  • Technical
  • Relative Strength Index (RSI)
  • DYAI 36.54
  • CIF 42.38
  • Support Level
  • DYAI $0.88
  • CIF $1.68
  • Resistance Level
  • DYAI $0.98
  • CIF $1.79
  • Average True Range (ATR)
  • DYAI 0.08
  • CIF 0.02
  • MACD
  • DYAI -0.02
  • CIF 0.00
  • Stochastic Oscillator
  • DYAI 11.93
  • CIF 50.00

About DYAI Dyadic International Inc.

Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.

About CIF MFS Intermediate High Income Fund

Mfs Intermediate High Income Fund is a United States based diversified closed-end management investment company. Its investment objective is to seek high current income but may also consider capital appreciation. The fund invests a majority of its net assets, including borrowings for investment purposes, in high-income debt instruments. Its portfolio of investments includes investment grade corporate bonds, government securities and other securities.

Share on Social Networks: